ACTIVE_NOT_RECRUITING

Developing Inclusive Support and Intervention for Spanish-speaking Latiné Prostate Cancer Survivors

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Prostate cancer is a significant concern for Latiné men, with over 17,000 new cases annually. Decision-making for treatment is complex, especially due to barriers like low health literacy and cultural factors. Research on survivorship and post-treatment issues like erectile dysfunction is lacking. To improve care, a study will engage 288 participants across various medical facilities, including 100 at Cleveland Clinic. Thirty subjects will participate in focus groups representing Spanish-speaking Latiné, bilingual Latiné, and English-speaking non-Latiné individuals to understand their perspectives and enhance communication. This aims to develop tailored resources, like Spanish-language educational videos, addressing language and cultural needs for informed decision-making.

Official Title

Developing Inclusive Support and Intervention for Spanish-speaking Latiné Prostate Cancer Survivors: Understanding Cultural Nuances in Survivorship Decision Making

Quick Facts

Study Start:2024-10-08
Study Completion:2026-07-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:ACTIVE_NOT_RECRUITING

Study ID

NCT06435871

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:MALE
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Adults \>18 years
  2. * Diagnosis of Localized Prostate Cancer
  3. * Underwent radical prostatectomy by their urological surgeon
  4. * Subjects must have the ability to understand and the willingness to sign a written informed consent document
  1. * Patient whose primary language is not English or Spanish
  2. * Patients who had brachytherapy and/or radiation treatment as their initial treatment
  3. * Patients with disease progression at time study recruitment who are requiring other treatments (ADT, chemotherapy, immunotherapy)
  4. * Patients who underwent current non-standard prior treatment options for localized prostate cancer including cryotherapy and high intensity focused ultrasound (HIFU)

Contacts and Locations

Principal Investigator

Christopher Weight, MD
PRINCIPAL_INVESTIGATOR
Cleveland Clinic Glickman Urological and Kidney Institute, Cleveland Clinic Foundation, Case Comprehensive Cancer Center

Study Locations (Sites)

Cleveland Clinic Glickman Urological and Kidney Institute, Cleveland Clinic Foundation, Case Comprehensive Cancer Center
Cleveland, Ohio, 44195
United States

Collaborators and Investigators

Sponsor: Case Comprehensive Cancer Center

  • Christopher Weight, MD, PRINCIPAL_INVESTIGATOR, Cleveland Clinic Glickman Urological and Kidney Institute, Cleveland Clinic Foundation, Case Comprehensive Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-10-08
Study Completion Date2026-07-01

Study Record Updates

Study Start Date2024-10-08
Study Completion Date2026-07-01

Terms related to this study

Keywords Provided by Researchers

  • Latinos

Additional Relevant MeSH Terms

  • Prostate Cancer